- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Medical Bulletin 4/August/2023 - Video
Overview
Here are the top medical news of the day:
Bipolar depression relapse risk reduced by modern antidepressants
Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the University of British Columbia. Patients with bipolar disorder experience extreme changes in their emotional state that cycle through periods of intense highs and lows.
Results from the world’s first randomized clinical trial assessing the duration of adjunctive antidepressant therapy for the condition, suggest that extending the treatment period beyond current guidelines may help prevent depressive relapses
Reference: New England Journal of Medicine, DOI 10.1056/NEJMoa2300184
Potential risks of antenatal steroids highlighted in new study
Two new studies published by The BMJ recently examine the potential health risks for infants of giving steroid drugs to women who are at risk of giving birth early.
Corticosteroids are known to help increase the chance of a baby born early surviving and having fewer health problems. Ideally, they should be given before 34 weeks of pregnancy and within approximately one week of birth. But their effects on later childhood health are less well understood, particularly when administration is “mistimed” and infants are born at term.
Reference: The BMJ, Antenatal corticosteroids and longer term outcomes DOI 10.1136/bmj.p1722
Novel HIV drug formulation could improve treatment outcomes for children globally
Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).
The study was published in The Lancet HIV and reveals a new dispersible formulation and an immediate-release tablet containing three medications - dolutegravir, abacavir and lamivudine - in a single fixed dose combination (FDC) formulation is safe, well tolerated, and effective for treating children with HIV. The dosing based on the concentrations of each medication in the blood was also appropriate.
Reference: Kristina Brooks et al, The Lancet HIV. doi.org/10.1016/S2352-3018(23)00107-8.
Speakers
Isra Zaman
B.Sc Life Sciences, M.Sc Biotechnology, B.Ed